我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

高脂血症早期血管脂联素抵抗受体前机制的探讨

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2017年第6期
页码:
631-635
栏目:
基础研究
出版日期:
2017-06-01

文章信息/Info

Title:
Mechanism of vascular adiponectin resistance in early phase of hyperlipidemia at the pre-receptor Level
作者:
樊 森; 戴建立; 王晓明; 李 榕
（第四军医大学西京医院老年病科，陕西 西安 710032）
Author(s):
FAN Sen;  DAI Jian-li;  WANG Xiao-ming;  LI Rong
(Department of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
关键词:
脂联素抵抗; 高脂血症; 载脂蛋白A1; 载脂蛋白C1
Keywords:
adiponectin resistance;  hyperlipidemia;  ApoA1;  ApoC1
分类号:
R587.1
DOI:
-
文献标识码:
A
摘要:
目的 明确高脂血症早期血管脂联素（APN）抵抗是否与高脂血浆中血管活性物质与APN结合并抑制其生物活性有关。方法 将20只雄性SD大鼠随机分为对照组和高脂血症组，每组10只，分别饲以正常及高脂饮食8周。喂养结束后，麻醉采血检测血浆中总胆固醇(TC)、三酰甘油（TG）、高密度脂蛋白胆固醇（HDL-C）、低密度脂蛋白胆固醇（LDL-C）和APN的水平。采用免疫共沉淀法沉淀血浆中的APN，质谱分析法分析血浆中能够与APN结合的血管活性物质。将初步得到的血管活性物质与重组人APN（rAPN）共孵育，观察孵育后的rAPN对人脐静脉内皮细胞（HUVECs）中腺苷酸活化的蛋白激酶（AMPK）磷酸化（p-AMPK）水平的影响。结果 与喂养正常饲料组相比，以高脂饲料喂养8周后，大鼠TC、TG、HDL-C、LDL-C、APN及血糖的含量显著升高（P<0.05或P<0.01）。将正常及高脂饲料喂养大鼠的血浆用APN抗体进行免疫共沉淀并进一步行质谱分析后，发现载脂蛋白（Apo）A1、ApoC1、对氧磷酶（PON）1等18种血管活性物质与高脂血浆中APN结合显著增多（P<0.01）。其中ApoA1在血浆中含量显著升高（P<0.05），此外，ApoA1及ApoC1可显著抑制rAPN对HUVECs中7-AMPK水平（P<0.01或P<0.05）。结论 高脂血症早期大鼠血管APN抵抗与高脂血浆中Apo水平升高、结合并抑制APN活性有关。
Abstract:
AIM To identify whether vascular activity factors that can combine and inhibit the ability of APN are relate to vascular APN resistance in early phase hyperlipidemia.METHODS Twenty male Sprague Dawley rats were divided equally into control group and hyperlipidemia group randomly, receive regular diet or high-fat diet for 8 weeks, then triglyceride, total cholesterol, high-density lipoprotein, low-density lipoprotein in circulation were determined. Plasma from regular diet and high-fat diet rats was applied co-immunoprecipitation with anti-APN antibody to precipitate plasma APN then followed mass spectrometric analysis to determine which vascular activity factors can combine with APN.Pre-incubated rAPN with vascular activity factors which discovered in former step and observed the AMPK activation effect of rAPN in HUVECs.RESULTS Compared with rats fed with regular diet rats fed with high-fat diet triglyceride, total cholesterol, high-density lipoprotein, low-density lipoprotein and APN levels in circulation were obviously raised(P<0.05 or P<0.01)after 8 weeks.Discovered ApoA1,ApoC1,PON1 along with other fifteen vascular activity factors can combine APN and the ability of combination significantly increased in hyperlipidemia plasma (P<0.01).Among the eighteen vascular activity factors ApoA1 significantly increased in hyperlipidemia plasma (P<0.05),ApoA1 and ApoC1 can significantly inhibit the ability of rAPN to phosphorylate AMPK in HUVECs (P<0.01 or P<0.05).CONCLUSION Increased apolipoprotein that can combine and inhibit the activity of APN in hyperlipidemic plasma is likely responsible for vascular APN resistance in early phase hyperlipidemia.

参考文献/References

[1]Yamauchi T,Iwabu M,Okada-Iwabu M,et al.Adiponectin receptors:A review of their structure, function and how they work[J].Best Pract Res Clin Endocrinol Metab,2014,28(1):15-23.
[2]Lau WB,Tao L,Wang Y,et al.Systemic adiponectin malfunction as a risk factor for cardiovascular disease[J].Antioxid Redox Signal,2011,15(7):1863-1873.
[3]Warnholtz A,Mollnau H,Oelze M,et al.Antioxidants and endothelial dysfunction in hyperlipidemia[J].Curr Hypertens Rep,2001,3(1):53-60.
[4]Li R,Xu M,Wang X,et al.Reduced vascular responsiveness to adiponectin in hyperlipidemic rats-mechanisms and significance[J].J Mol Cell Cardiol,2010,49(3):508-515.
[5]王文清,张荣怀,王晓明,等.高胆固醇血症大鼠血管脂联素抵抗的机制探讨[J].心脏杂志,2011(04):450-454.
[6]Liu X,Ren K,Suo R,et al.ApoA-I induces S1P release from endothelial cells through ABCA1 and SR-BI in a positive feedback manner[J].J Physiol Biochem,2016,72(4):657-667.
[7]Wang F,Kohan AB,Kindel TL,et al.Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion[J].Proceedings of the National Academy of Sciences,2012,109(24):9641-9646.
[8]de Haan W,Out R,Berbée JFP,et al.Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo[J].Biochemical and Biophysical Research Communications,2008,377(4):1294-1298.
[9] Koren-Gluzer M,Aviram M,Hayek T.Paraoxonase1(PON1)reduces insulin resistance in mice fed a high-fat diet,and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway[J].Atherosclerosis,2013,229(1):71-78.
[10]de Seny D,Cobraiville G,Charlier E,et al.Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis:ex vivo and in vitro pro-inflammatory properties[J].PLOS ONE,2015,10(4):e122904.
[11]Canales A,Sanchez-Muniz FJ,Bastida S,et al.Effect of walnut-enriched meat on the relationship between VCAM,ICAM,and LTB4 levels and PON-1 activity in ApoA4 360 and PON-1 allele carriers at increased cardiovascular risk[J].Eur J Clin Nutr,2011,65(6):703-710.
[12]Kuai R,Li D,Chen YE,et al.High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles[J].ACS Nano,2016,10(3):3015-3041.
[13]Jong MC,Hofker MH,Havekes LM.Role of ApoCs in lipoprotein metabolism:functional differences between ApoC1,ApoC2,and ApoC3[J].Arterioscler Thromb Vasc Biol,1999,19(3):472-484.
[14]Mullen KL,Smith AC,Junkin KA,et al.Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats[J].Am J Physiol Endocrinol Metab,2007,293(1):E83-E90.
[15]Lin HV,Kim J,Pocai A,et al.Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice[J].Diabetes,2007,56(8):1969-1976.
[16]Liu G,Liang B,Lau WB,et al.High glucose/High Lipids impair vascular adiponectin function via inhibition of caveolin-1/AdipoR1 signalsome formation[J].Free Radic Biol Med,2015,89:473-485.
[17]Laoutaris ID,Vasiliadis IK,Dritsas A,et al.High plasma adiponectin is related to low functional capacity in patients with chronic heart failure[J].Int J Cardiol,2010,144(2):230-231.
[18]Van Berendoncks AM,Garnier A,Beckers P,et al.Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure[J].Circ Heart Fail,2010,3(2):185-194.
[19]Sente T,Van Berendoncks AM,Hoymans VY,et al.Adiponectin resistance in skeletal muscle:pathophysiological implications in chronic heart failure[J].J Cachexia Sarcopenia Muscle,2016,7(3):261-274.
[20]Khan RS,Kato TS,Chokshi A,et al.Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure:correction after ventricular assist device implantation[J].Circ Heart Fail,2012,5(3):340-348.
[21]Diamant M,Tushuizen ME.The metabolic syndrome and endothelial dysfunction:common highway to type 2 diabetes and CVD[J].Curr Diab Rep,2006,6(4):279-286.
[22]Li R,Wang WQ,Zhang H,et al.Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity[J].Am J Physiol Endocrinol Metab,2007,293(6):E1703-E1708.
[23]Margaritis M,Antonopoulos AS,Digby J,et al.Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels[J].Circulation,2013,127(22):2209-2221.
[24]Li R,Xu M,Wang X,et al.Reduced vascular responsiveness to adiponectin in hyperlipidemic rats-mechanisms and significance[J].J Mol Cell Cardiol,2010,49(3):508-515.
[25]Kalehsar NS,Golmohammadi T.Association between serum adiponectin and HDL-C in type II diabetic patients[J].Glob J Health Sci,2015,7(2):243-246.
[26]Kuai R,Li D,Chen YE,et al.High-Density Lipoproteins:Nature’s Multifunctional Nanoparticles[J].ACS Nano,2016,10(3):3015-3041.
[27]Mullen KL,Pritchard J,Ritchie I,et al.Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats[J].Am J Physiol Regul Integr Comp Physiol,2008,296(2):R243-R251.
[28]Kolmakova A,Kwiterovich P,Virgil D,et al.Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase[J].Arterioscler Thromb Vasc Biol,2004,24(2):264-269.
[29]Holland WL,Miller RA,Wang ZV,et al.Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin[J].Nat Med,2011,17(1):55-63.

备注/Memo

备注/Memo:
收稿日期：2017-02-24.基金项目：国家自然科学基金项目资助（81270401，81470413）；陕西省自然科学基础研究计划项目资助（2014JZ010）；陕西省卫计委科研项目资助（2016D002）
通讯作者：李榕，副主任医师，主要从事代谢综合征发病机制和防治研究 Email：wwqlrrs@fmmu.edu.cn
作者简介：樊森，硕士生 Email：fansen1@126.com
更新日期/Last Update: 2017-06-06